title: [Must platelet aggregation inhibitors be discontinued before surgery?].
authors.affiliation: Robert-Bosch-Krankenhaus, Stuttgart, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Schieber
authors.forename: U
authors.initials: U
authors.lastname: Sechtem
mesh_terms: D000792:Angiography; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D000077144:Clopidogrel; D006801:Humans; D010138:Pacemaker, Artificial; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin